Advertisement
Heart, Lung and Circulation
Abstract| Volume 20, ISSUE 4, P256, April 2011

Coronary Artery Bypass Grafting with and without Manipulation of the Aorta—A Meta-analysis

  • J.J.B. Edelman
    Correspondence
    Corresponding author.
    Affiliations
    Cardiothoracic Surgical Unit, Royal Prince Alfred Hospital, The University of Sydney, Sydney, Australia

    The Baird Institute, The University of Sydney, Sydney, Australia

    Faculty of Medicine, The University of Sydney, Sydney, Australia
    Search for articles by this author
  • T.D. Yan
    Affiliations
    Cardiothoracic Surgical Unit, Royal Prince Alfred Hospital, The University of Sydney, Sydney, Australia

    The Baird Institute, The University of Sydney, Sydney, Australia

    Faculty of Medicine, The University of Sydney, Sydney, Australia
    Search for articles by this author
  • R. Padang
    Affiliations
    Department of Cardiology, Royal Prince Alfred Hospital, Sydney, Australia
    Search for articles by this author
  • P.G. Bannon
    Affiliations
    Cardiothoracic Surgical Unit, Royal Prince Alfred Hospital, The University of Sydney, Sydney, Australia

    The Baird Institute, The University of Sydney, Sydney, Australia

    Faculty of Medicine, The University of Sydney, Sydney, Australia
    Search for articles by this author
  • M.P. Vallely
    Affiliations
    Cardiothoracic Surgical Unit, Royal Prince Alfred Hospital, The University of Sydney, Sydney, Australia

    The Baird Institute, The University of Sydney, Sydney, Australia

    Faculty of Medicine, The University of Sydney, Sydney, Australia
    Search for articles by this author
      Introduction: The SYNTAX trial showed that coronary artery bypass grafting remains the standard of treatment for left main and three-vessel coronary artery disease, with lower rates of major cardiac and cerebrovascular events and need for revascularisation at 12 months when compared to percutaneous coronary intervention. Surgery did, however, have a higher rate of stroke in the post-operative period (2.2% versus 0.6%) [
      • Serruys P.W.
      • Morice M.-C.
      • Kappetein A.P.
      • Colombo A.
      • Holmes D.R.
      • Mack M.J.
      • et al.
      Percutaneous coronary intervention versus coronary-artery bypass grafting for severe coronary artery disease.
      ].
      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'

      Subscribe:

      Subscribe to Heart, Lung and Circulation
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect

      References

        • Serruys P.W.
        • Morice M.-C.
        • Kappetein A.P.
        • Colombo A.
        • Holmes D.R.
        • Mack M.J.
        • et al.
        Percutaneous coronary intervention versus coronary-artery bypass grafting for severe coronary artery disease.
        N Engl J Med. 2009; 360: 961-972
        • Calafiore A.M.
        • Di Mauro M.
        • Teodori G.
        • Di Giammarco G.
        • Cirmeni S.
        • Contini M.
        • et al.
        Impact of aortic manipulation on incidence of cerebrovascular accidents after urgical myocardial revascularization.
        Ann Thorac Surg. 2002; 73: 1387-1393